Early Detection of Ovarian Cancer May Become Possible

December 28, 2015 7:21 pm

A new version of a screening test for ovarian cancer may reduce deaths from the disease, but it needs more study to determine whether the benefits hold up, researchers reported on Thursday.

The findings come from a 14-year study of … Read more

Gratitude Is Good For The Soul And Helps The Heart, Too

December 10, 2015 8:50 pm

Research shows that feeling grateful doesn’t just make you feel good. It also helps — literally helps — the heart.

A positive mental attitude is good for your heart. It fends off depression, stress and anxiety, which can increase the … Read more

Having Ovarian Cancer Is Like Performing in a Circus

December 2, 2015 7:15 pm

Imagine having no symptoms other than 2 tiny spots of postmenopausal bleeding a month apart. I called my gynecologist, who ordered a vaginal ultrasound, and I was diagnosed with stage III ovarian cancer (meaning it had spread outside the abdominal … Read more

Knowing About Ovarian Cancer May Save Your Life!

December 1, 2015 8:03 pm

Suppose the mammography had never been invented—how much would we know today about breast cancer? Without it, how many more women might have died from breast cancer? Unlike mammography, no routine test, such as a Pap smear, can yet detect … Read more

What I’m Grateful For, Thanksgiving 2015

November 24, 2015 10:51 pm

What are you grateful for this Thanksgiving? Annette McElhiney, ovarian cancer survivor and advocate, has much to be thankful for this year and every year. She wrote a post for the Clearity Portal. Read an excerpt below.

I’m grateful to … Read more

Molecular Profiling As a Necessity for Uncommon Ovarian Cancers

November 5, 2015 11:00 am

By: Laura Shawver

In 1998, Herceptin was approved for women with breast cancer whose tumors have extra copies of the Her2/ERBB2 gene and since that time, there have been more than 25 drugs approved to treat cancers with specific genetic … Read more

Why Are Many Women At Risk of Ovarian Cancer Not Aware Of It?

November 2, 2015 11:00 am

The statistics for ovarian cancer are frightening. Whereas early detection tests for breast cancer are relatively commonplace, 75-85% of women with ovarian cancer are diagnosed only at a late stage, when the cancer has spread and prognosis is poor.

More … Read more

Effective Ovarian Cancer Treatment Is Underused, Study Finds

October 30, 2015 11:00 am

Deborah Denehy received chemotherapy directly to her abdomen to treat ovarian cancer, a treatment that remains underused in the United States. Credit Shiho Fukada for The New York Times.

In 2006, the National Cancer Institute took the rare step … Read more

Liz Laats Shares Her Story at Clearity’s Glitter and Glue for Good

October 27, 2015 11:00 am

Check out Liz Laats’ amazing speech at Glitter and Glue for Good, not a dry eye in the house.

Thank you to everyone who joined us on March 7th for the inaugaural Glitter & Glue for Good event. More than … Read more

Molecular Profiling of Epithelial Ovarian Cancer

October 24, 2015 11:00 am

Epithelial ovarian cancer (EOC) is the most common cause of gynecological cancer death in the United States, with an estimated 21,290 new cases and 14,180 deaths estimated for 2015 (ACS 2015). The vast majority of women are diagnosed with advanced … Read more

Heart Drug Linked to Extra Years for Cancer Patients

October 20, 2015 11:00 am

A common heart drug called a beta blocker was associated with a striking increase in survival for women with ovarian cancer in a study that suggests a possible new strategy for treating a variety of tumors.

Researchers analyzing a database … Read more

A Heart to Heart Community for Ovarian Cancer Survivors

October 17, 2015 11:00 am

Welcome to my Heart to Heart blog designed in the Clearity Portal to provide ovarian cancer survivors with a “cozy space” where we know we will be welcomed and supported.

I’ve been an ovarian cancer survivor for 7 years. I’ve … Read more

Novel Clinical Trial Designs Match Drugs to Patient’s Tumor Profiles

September 1, 2014 8:07 pm

By: Cory Bentley, PhD

Bringing new treatments to ovarian cancer patients is very challenging.  There are not as many patients diagnosed with this cancer as there are with other cancer types, such as breast, lung and colorectal, so there are … Read more

Eligibility Criteria in Clinical Trials: PARP Inhibitors

July 1, 2013 7:59 pm

By: Cory Bentley, PhD

Clearity first reported on drugs inhibiting PARP (Poly-ADP ribose polymerase), an important enzyme for tumor cell proliferation and survival, in its September 2010 patient newsletter.  At that time, PARP inhibitors were just entering clinical trials and

Read more